Skip to main content
NCBI home page
Gut logoLink to Gut
. 1984 Dec;25(12):1416–1423. doi: 10.1136/gut.25.12.1416

Assessing the safety of drugs for the long-term treatment of peptic ulcers.

K G Wormsley
PMCID: PMC1420192  PMID: 6150883

Full text

PDF
1416

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Alumets J., El Munshid H. A., Håkanson R., Liedberg G., Oscarson J., Rehfeld J. F., Sundler F. Effect of antrum exclusion on endocrine cells of rat stomach. J Physiol. 1979 Jan;286:145–155. doi: 10.1113/jphysiol.1979.sp012610. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. Assad R. T., Eastwood G. L. Epithelial proliferation in human fundic mucosa after antrectomy and vagotomy. Gastroenterology. 1980 Nov;79(5 Pt 1):807–811. [PubMed] [Google Scholar]
  3. Banks W. A., Kastin A. J. Aluminium increases permeability of the blood-brain barrier to labelled DSIP and beta-endorphin: possible implications for senile and dialysis dementia. Lancet. 1983 Nov 26;2(8361):1227–1229. doi: 10.1016/s0140-6736(83)91273-4. [DOI] [PubMed] [Google Scholar]
  4. Barale R., Zucconi D., Romano M., Loprieno N. The intragastric host-mediated assay for the assessment of the formation of direct mutagens in vivo. Mutat Res. 1983 Feb;113(1):21–32. doi: 10.1016/0165-1161(83)90238-8. [DOI] [PubMed] [Google Scholar]
  5. Betton G. R., Salmon G. K. Pathology of the forestomach in rats treated for 1 year with a new histamine H2-receptor antagonist, SK&F 93479 trihydrochloride. Scand J Gastroenterol Suppl. 1984;101:103–108. [PubMed] [Google Scholar]
  6. Bordi C., Gabrielli M., Missale G. Pathologic changes of endocrine cells in chronic atrophic gastritis. An ultrastructural study on peroral gastric biopsy specimens. Arch Pathol Lab Med. 1978 Mar;102(3):129–135. [PubMed] [Google Scholar]
  7. Bowdler N. C., Beasley D. S., Fritze E. C., Goulette A. M., Hatton J. D., Hession J., Ostman D. L., Rugg D. J., Schmittdiel C. J. Behavioral effects of aluminum ingestion on animal and human subjects. Pharmacol Biochem Behav. 1979 Apr;10(4):505–512. doi: 10.1016/0091-3057(79)90225-9. [DOI] [PubMed] [Google Scholar]
  8. Boyd E. J., Wilson J. A., Wormsley K. G. Review of ulcer treatment: role of ranitidine. J Clin Gastroenterol. 1983;5 (Suppl 1):133–141. doi: 10.1097/00004836-198312001-00013. [DOI] [PubMed] [Google Scholar]
  9. Brittain R. T., Harris D. M., Martin L. E., Poynter D., Price B. J. Safety of ranitidine. Lancet. 1981 Nov 14;2(8255):1119–1119. doi: 10.1016/s0140-6736(81)91328-3. [DOI] [PubMed] [Google Scholar]
  10. Burland W. L., Hawkins B. W., Beresford J. Cimetidine treatment for the prevention of recurrence of duodenal ulcer: an international collaborative study. Postgrad Med J. 1980 Mar;56(653):173–176. doi: 10.1136/pgmj.56.653.173. [DOI] [PMC free article] [PubMed] [Google Scholar]
  11. Campbell T. C. Chemical carcinogens and human risk assessment. Fed Proc. 1980 Jun;39(8):2467–2484. [PubMed] [Google Scholar]
  12. Capria A., Bresci G., Polloni A., Rindi G., Geloni M., Del Tacca M. Pirenzepine in long-term therapy for duodenal ulcer. Int J Clin Pharmacol Ther Toxicol. 1983 Aug;21(8):422–424. [PubMed] [Google Scholar]
  13. Carney J. A., Go V. L., Fairbanks V. F., Moore S. B., Alport E. C., Nora F. E. The syndrome of gastric argyrophil carcinoid tumors and nonantral gastric atrophy. Ann Intern Med. 1983 Dec;99(6):761–766. doi: 10.7326/0003-4819-99-6-761. [DOI] [PubMed] [Google Scholar]
  14. Colin-Jones D. G., Langman M. J., Lawson D. H., Vessey M. P. Cimetidine and gastric cancer: preliminary report from post-marketing surveillance study. Br Med J (Clin Res Ed) 1982 Nov 6;285(6351):1311–1313. doi: 10.1136/bmj.285.6351.1311. [DOI] [PubMed] [Google Scholar]
  15. Correa P. Precursors of gastric and esophageal cancer. Cancer. 1982 Dec 1;50(11 Suppl):2554–2565. [PubMed] [Google Scholar]
  16. Crapper D. R., Krishnan S. S., Quittkat S. Aluminium, neurofibrillary degeneration and Alzheimer's disease. Brain. 1976 Mar;99(1):67–80. doi: 10.1093/brain/99.1.67. [DOI] [PubMed] [Google Scholar]
  17. Crean G. P., Morson B. C., Leslie G. B., Roe F. J. Cimetidine: further evidence of noncarcinogenicity in dogs. N Engl J Med. 1981 Mar 12;304(11):672–672. doi: 10.1056/NEJM198103123041119. [DOI] [PubMed] [Google Scholar]
  18. Dahm K., Werner B. Susceptibility of the resected stomach to experimental carcinogenesis. Z Krebsforsch Klin Onkol Cancer Res Clin Oncol. 1976 Mar 19;85(3):219–229. doi: 10.1007/BF00284082. [DOI] [PubMed] [Google Scholar]
  19. Dawson J., Richards D. A., Stables R., Dixon G. T., Cockel R. Ranitidine--pharmacology and clinical use. J Clin Hosp Pharm. 1983 Mar;8(1):1–13. doi: 10.1111/j.1365-2710.1983.tb00892.x. [DOI] [PubMed] [Google Scholar]
  20. De Flora S., Bennicelli C., Camoirano A., Zanacchi P. Genotoxicity of nitrosated ranitidine. Carcinogenesis. 1983;4(3):255–260. doi: 10.1093/carcin/4.3.255. [DOI] [PubMed] [Google Scholar]
  21. De Flora S., Bennicelli C., Camoirano A., Zanacchi P. Genotoxicity of nitrosated ranitidine. Carcinogenesis. 1983;4(3):255–260. doi: 10.1093/carcin/4.3.255. [DOI] [PubMed] [Google Scholar]
  22. Dick W., Rösch W. Rezidivulkus und -karzinom im operierten Magen. Med Welt. 1981 Apr 17;32(16):611–612. [PubMed] [Google Scholar]
  23. Eastwood G. L., Quimby G. F. Effect of chronic cimetidine ingestion on fundic and antral epithelial proliferation in the rat. Dig Dis Sci. 1983 Jan;28(1):61–64. doi: 10.1007/BF01393362. [DOI] [PubMed] [Google Scholar]
  24. Elder J. B., Ganguli P. C., Gillespie I. E. Cimetidine and gastric cancer. Lancet. 1979 May 12;1(8124):1005–1006. doi: 10.1016/s0140-6736(79)92757-0. [DOI] [PubMed] [Google Scholar]
  25. Ellis D. J., Kingston R. D., Brookes V. S., Waterhouse J. A. Gastric carcinoma and previous peptic ulceration. Br J Surg. 1979 Feb;66(2):117–119. doi: 10.1002/bjs.1800660211. [DOI] [PubMed] [Google Scholar]
  26. Farber E. Chemical carcinogenesis: a biologic perspective. Am J Pathol. 1982 Feb;106(2):271–296. [PMC free article] [PubMed] [Google Scholar]
  27. Farrands P. A., Blake J. R., Ansell I. D., Cotton R. E., Hardcastle J. D. Endoscopic review of patients who have had gastric surgery. Br Med J (Clin Res Ed) 1983 Mar 5;286(6367):755–758. doi: 10.1136/bmj.286.6367.755. [DOI] [PMC free article] [PubMed] [Google Scholar]
  28. Fischer A. B., Graem N., Jensen O. M. Risk of gastric cancer after Billroth II resection for duodenal ulcer. Br J Surg. 1983 Sep;70(9):552–554. doi: 10.1002/bjs.1800700915. [DOI] [PubMed] [Google Scholar]
  29. Fishbein L. Overview of some aspects of quantitative risk assessment. J Toxicol Environ Health. 1980 Sep-Nov;6(5-6):1275–1296. doi: 10.1080/15287398009529947. [DOI] [PubMed] [Google Scholar]
  30. Fort L., Taper H. S., Brucher J. M. Gastric carcinogenesis in rat induced by methylnitrosourea (MNU). Morphology, and histochemistry of nucleases. Z Krebsforsch Klin Onkol Cancer Res Clin Oncol. 1974 Mar 14;81(1):51–62. doi: 10.1007/BF00303600. [DOI] [PubMed] [Google Scholar]
  31. Fujita M., Takami M., Usugane M., Nampei S., Taguchi T. Enhancement of gastric carcinogenesis in dogs given N-methyl-N'-nitro-N-nitrosoguanidine following vagotomy. Cancer Res. 1979 Mar;39(3):811–816. [PubMed] [Google Scholar]
  32. Gabriel R., Morgan J. Aluminium sucrose biscuit fillings to control hyperphosphataemia in patients undergoing dialysis. Br Med J (Clin Res Ed) 1981 Jul 25;283(6286):268–268. doi: 10.1136/bmj.283.6286.268. [DOI] [PMC free article] [PubMed] [Google Scholar]
  33. Gatehouse D. G., Tweats D. J. Mutagen formation after the addition of nitrite to normal human gastric juice. Carcinogenesis. 1982;3(5):597–598. doi: 10.1093/carcin/3.5.597. [DOI] [PubMed] [Google Scholar]
  34. Giacosa A., Cheli R., Bertaccini G., Bocchini R. Does cimetidine play a "proinflammatory" role in fundic mucosa of duodenal ulcer patients? Acta Gastroenterol Belg. 1980 May-Jun;43(5-6):167–172. [PubMed] [Google Scholar]
  35. Gorsky J. E., Dietz A. A., Spencer H., Osis D. Metabolic balance of aluminum studied in six men. Clin Chem. 1979 Oct;25(10):1739–1743. [PubMed] [Google Scholar]
  36. Habs M., Eisenbrand G., Habs H., Schmähl D. No evidence of carcinogenicity of N-nitrosocimetidine in rats. Hepatogastroenterology. 1982 Dec;29(6):265–266. [PubMed] [Google Scholar]
  37. Hansen O. H., Larsen J. K., Svendsen L. B. Changes in gastric mucosal cell proliferation after antrectomy or vagotomy in man. Scand J Gastroenterol. 1978;13(8):947–952. doi: 10.3109/00365527809181374. [DOI] [PubMed] [Google Scholar]
  38. Hicks R. M. Pathological and biochemical aspects of tumour promotion. Carcinogenesis. 1983 Oct;4(10):1209–1214. doi: 10.1093/carcin/4.10.1209. [DOI] [PubMed] [Google Scholar]
  39. Jensen D. E. Deoxyribonucleic acid methylation in human cells exposed to nitrosocimetidine. Biochem Pharmacol. 1981 Oct;30(20):2864–2867. doi: 10.1016/0006-2952(81)90427-5. [DOI] [PubMed] [Google Scholar]
  40. Jerzy Glass G. B., Pitchumoni C. S. Structural and ultrastructural alterations, exfoliative cytology and enzyme cytochemistry and histochemistry, proliferation kinetics, immunological derangements and other causes, and clinical associations and sequallae. Hum Pathol. 1975 Mar;6(2):219–250. [PubMed] [Google Scholar]
  41. Kay P. H., Moore K. T., Clark R. G. The treatment of perforated duodenal ulcer. Br J Surg. 1978 Nov;65(11):801–803. doi: 10.1002/bjs.1800651111. [DOI] [PubMed] [Google Scholar]
  42. Kekki M., Ihamäki T., Saukkonen M., Varis K., Siurala M. Progression of gastritis at a population level. Comparison of a long-term follow-up with stochastic analysis of cross-sectional data. Scand J Gastroenterol. 1980;15(6):651–655. doi: 10.3109/00365528009181511. [DOI] [PubMed] [Google Scholar]
  43. Kekki M., Saukkonen M., Sipponen P., Varis K., Siurala M. Dynamics of chronic gastritis in the remnant after partial gastrectomy for duodenal ulcer. Scand J Gastroenterol. 1980;15(4):509–512. doi: 10.3109/00365528009181509. [DOI] [PubMed] [Google Scholar]
  44. Langhans P., Heger R. A., Stegemann B. The cancer risk in the stomach subjected to nonresecting procedures. An experimental long-term study. Scand J Gastroenterol Suppl. 1984;92:138–141. [PubMed] [Google Scholar]
  45. Lehy T., Voillemot N., Dubrasquet M., Dufougeray F. Gastrin cell hyperplasia in rats with chronic antral stimulation. Gastroenterology. 1975 Jan;68(1):71–82. [PubMed] [Google Scholar]
  46. Leung A. C., Henderson I. S., Halls D. J., Dobbie J. W. Aluminium hydroxide versus sucralfate as a phosphate binder in uraemia. Br Med J (Clin Res Ed) 1983 Apr 30;286(6375):1379–1381. doi: 10.1136/bmj.286.6375.1379. [DOI] [PMC free article] [PubMed] [Google Scholar]
  47. Lewis J. H., Woods M., 3rd Gastric carcinoma in patients with unoperated duodenal ulcer disease. Am J Gastroenterol. 1982 Jun;77(6):368–373. [PubMed] [Google Scholar]
  48. Libeskind M. Maintenance treatment of patients with healed peptic ulcer with sucralfate, placebo and cimetidine. Scand J Gastroenterol Suppl. 1983;83:69–70. [PubMed] [Google Scholar]
  49. Lijinsky W., Reuber M. D. Comparison of nitrosocimetidine with nitrosomethylnitroguanidine in chronic feeding tests in rats. Cancer Res. 1984 Feb;44(2):447–449. [PubMed] [Google Scholar]
  50. Logan R. F., Langman M. J. Screening for gastric cancer after gastric surgery. Lancet. 1983 Sep 17;2(8351):667–670. doi: 10.1016/s0140-6736(83)92541-2. [DOI] [PubMed] [Google Scholar]
  51. Lupulescu A. Enhancement of carcinogenesis by prostaglandins. Nature. 1978 Apr 13;272(5654):634–636. doi: 10.1038/272634a0. [DOI] [PubMed] [Google Scholar]
  52. Markesbery W. R., Ehmann W. D., Hossain T. I., Alauddin M., Goodin D. T. Instrumental neutron activation analysis of brain aluminum in Alzheimer disease and aging. Ann Neurol. 1981 Dec;10(6):511–516. doi: 10.1002/ana.410100604. [DOI] [PubMed] [Google Scholar]
  53. Marquis J. K. Aluminum neurotoxicity: an experimental perspective. Bull Environ Contam Toxicol. 1982 Jul;29(1):43–49. doi: 10.1007/BF01606087. [DOI] [PubMed] [Google Scholar]
  54. McDermott J. R., Smith A. I., Iqbal K., Wisniewski H. M. Brain aluminum in aging and Alzheimer disease. Neurology. 1979 Jun;29(6):809–814. doi: 10.1212/wnl.29.6.809. [DOI] [PubMed] [Google Scholar]
  55. Meister H., Schlag P., Weber E., Böckler R., Merkle P. Frequency of cancerous and precancerous epithelial lesions in the stomach in different models for enterogastric reflux. Scand J Gastroenterol Suppl. 1981;67:165–168. [PubMed] [Google Scholar]
  56. Mignon M., Berrezag R. Le traitement d'entretien de la maladie ulcéreuse duodénale par référence à l'histoire naturelle de la maladie. Résultats, indications et servitudes. Chirurgie. 1981 Jun;107(7):527–532. [PubMed] [Google Scholar]
  57. Morgan J. E., Kaiser C. W., Johnson W., Doos W. G., Dayal Y., Berman L., Nabseth D. Gastric carcinoid (gastrinoma) associated with achlorhydria (pernicious anemia). Cancer. 1983 Jun 15;51(12):2332–2340. doi: 10.1002/1097-0142(19830615)51:12<2332::aid-cncr2820511228>3.0.co;2-i. [DOI] [PubMed] [Google Scholar]
  58. Mori H., Domellöf L., Weisburger J. H., Williams G. M. Enhancing effect of vagotomy and pyloroplasty on gastro-intestinal carcinogenesis induced by nitrosamide in hamsters. Gan. 1981 Jun;72(3):440–445. [PubMed] [Google Scholar]
  59. Morson B. C., Sobin L. H., Grundmann E., Johansen A., Nagayo T., Serck-Hanssen A. Precancerous conditions and epithelial dysplasia in the stomach. J Clin Pathol. 1980 Aug;33(8):711–721. doi: 10.1136/jcp.33.8.711. [DOI] [PMC free article] [PubMed] [Google Scholar]
  60. Moshal M. G., Spitaels J. M., Khan F., Manion G. L. Pirenzepine, cimetidine and placebo in the long-term treatment of duodenal ulceration. A comparative study. S Afr Med J. 1982 Jul 3;62(1):12–14. [PubMed] [Google Scholar]
  61. Muscroft T. J., Youngs D. J., Burdon D. W., Keighley M. R. Cimetidine is unlikely to increase formation of intragastric N-nitroso-compounds in patients taking a normal diet. Lancet. 1981 Feb 21;1(8217):408–410. doi: 10.1016/s0140-6736(81)91791-8. [DOI] [PubMed] [Google Scholar]
  62. Orlando R., 3rd, Welch J. P. Carcinoma of the stomach after gastric operation. Am J Surg. 1981 Apr;141(4):487–491. doi: 10.1016/0002-9610(81)90145-8. [DOI] [PubMed] [Google Scholar]
  63. Perl D. P., Brody A. R. Alzheimer's disease: X-ray spectrometric evidence of aluminum accumulation in neurofibrillary tangle-bearing neurons. Science. 1980 Apr 18;208(4441):297–299. doi: 10.1126/science.7367858. [DOI] [PubMed] [Google Scholar]
  64. Preussmann R. Carcinogenic N-nitroso compounds and their environmental significance. Naturwissenschaften. 1984 Jan;71(1):25–30. doi: 10.1007/BF00365976. [DOI] [PubMed] [Google Scholar]
  65. Recker R. R., Blotcky A. J., Leffler J. A., Rack E. P. Evidence of aluminum absorption from the gastrointestinal tract and bone deposition by aluminum carbonate ingestion with normal renal function. J Lab Clin Med. 1977 Nov;90(5):810–815. [PubMed] [Google Scholar]
  66. Reed P. I., Smith P. L., Haines K., House F. R., Walters C. L. Effect of cimetidine on gastric juice N-nitrosamine concentration. Lancet. 1981 Sep 12;2(8246):553–556. doi: 10.1016/s0140-6736(81)90940-5. [DOI] [PubMed] [Google Scholar]
  67. Reinhart W. H., Müller O., Halter F. Influence of long-term 16,16-dimethyl prostaglandin E2 treatment on the rat gastrointestinal mucosa. Gastroenterology. 1983 Nov;85(5):1003–1010. [PubMed] [Google Scholar]
  68. Ross A. H., Smith M. A., Anderson J. R., Small W. P. Late mortality after surgery for peptic ulcer. N Engl J Med. 1982 Aug 26;307(9):519–522. doi: 10.1056/NEJM198208263070902. [DOI] [PubMed] [Google Scholar]
  69. Ruddell W. S., Bone E. S., Hill M. J., Walters C. L. Pathogenesis of gastric cancer in pernicious anaemia. Lancet. 1978 Mar 11;1(8063):521–523. doi: 10.1016/s0140-6736(78)90550-0. [DOI] [PubMed] [Google Scholar]
  70. Ryser H. J. Chemical carcinogenesis. N Engl J Med. 1971 Sep 23;285(13):721–734. doi: 10.1056/NEJM197109232851305. [DOI] [PubMed] [Google Scholar]
  71. Scanlan R. A. Formation and occurrence of nitrosamines in food. Cancer Res. 1983 May;43(5 Suppl):2435s–2440s. [PubMed] [Google Scholar]
  72. Schafer L. W., Larson D. E., Melton L. J., 3rd, Higgins J. A., Ilstrup D. M. The risk of gastric carcinoma after surgical treatment for benign ulcer disease. A population-based study in Olmsted County, Minnesota. N Engl J Med. 1983 Nov 17;309(20):1210–1213. doi: 10.1056/NEJM198311173092003. [DOI] [PubMed] [Google Scholar]
  73. Schmähl D., Habs M. Carcinogenicity of N-nitroso compounds. Species and route differences in regard to organotropism. Oncology. 1980;37(4):237–242. doi: 10.1159/000225444. [DOI] [PubMed] [Google Scholar]
  74. Schramm T., Teichmann B. Chemical carcinogens: screening, testing, risk assessment for man. Neoplasma. 1981;28(2):129–131. [PubMed] [Google Scholar]
  75. Scott R. E., Wille J. J., Jr, Wier M. L. Mechanisms for the initiation and promotion of carcinogenesis: a review and a new concept. Mayo Clin Proc. 1984 Feb;59(2):107–117. doi: 10.1016/s0025-6196(12)60244-4. [DOI] [PubMed] [Google Scholar]
  76. Siurala M. Gastritis, its fate and sequelae. Ann Clin Res. 1981 Jun;13(3):111–113. [PubMed] [Google Scholar]
  77. Slanina P., Falkeborn Y., Frech W., Cedergren A. Aluminium concentrations in the brain and bone of rats fed citric acid, aluminium citrate or aluminium hydroxide. Food Chem Toxicol. 1984 May;22(5):391–397. doi: 10.1016/0278-6915(84)90369-7. [DOI] [PubMed] [Google Scholar]
  78. Spencer H., Lender M. Adverse effects of aluminum-containing antacids on mineral metabolism. Gastroenterology. 1979 Mar;76(3):603–606. [PubMed] [Google Scholar]
  79. Stegemann B. Zur Karzinogenese nach Vagotomie. Tierexperimentelle Langzeituntersuchungen. Fortschr Med. 1982 Apr 8;100(13):586–591. [PubMed] [Google Scholar]
  80. Steiner K., Bühring K. U., Faro H. P., Garbe A., Nowak H. Sucralfate: pharmacokinetics, metabolism and selective binding to experimental gastric and duodenal ulcers in animals. Arzneimittelforschung. 1982;32(5):512–518. [PubMed] [Google Scholar]
  81. Stockbrugger R. W., Cotton P. B., Eugenides N., Bartholomew B. A., Hill M. J., Walters C. L. Intragastric nitrites, nitrosamines, and bacterial overgrowth during cimetidine treatment. Gut. 1982 Dec;23(12):1048–1054. doi: 10.1136/gut.23.12.1048. [DOI] [PMC free article] [PubMed] [Google Scholar]
  82. Streett C. S., Cimprich R. E., Robertson J. L. Pathologic findings in the stomachs of rats treated with the H2-receptor antagonist tiotidine. Scand J Gastroenterol Suppl. 1984;101:109–117. [PubMed] [Google Scholar]
  83. Tannenbaum S. R. N-nitroso compounds: a perspective on human exposure. Lancet. 1983 Mar 19;1(8325):629–632. doi: 10.1016/s0140-6736(83)91801-9. [DOI] [PubMed] [Google Scholar]
  84. Watt P. C., Sloan J. M., Kennedy T. L. Changes in gastric mucosa after vagotomy and gastrojejunostomy for duodenal ulcer. Br Med J (Clin Res Ed) 1983 Nov 12;287(6403):1407–1410. doi: 10.1136/bmj.287.6403.1407. [DOI] [PMC free article] [PubMed] [Google Scholar]
  85. Weisburger J. H., Williams G. M. Carcinogen testing: current problems and new approaches. Science. 1981 Oct 23;214(4519):401–407. doi: 10.1126/science.7291981. [DOI] [PubMed] [Google Scholar]

Articles from Gut are provided here courtesy of BMJ Publishing Group

RESOURCES